Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,466.67p
   
  • Change Today:
      16.67p
  • 52 Week High: 4,050.00
  • 52 Week Low: 2,300.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,271
  • Market Cap: £128.88m
  • Beta: 0.00

Bioventix appoints Bruce Hiscox as chief financial officer

By Iain Gilbert

Date: Wednesday 01 Jul 2020

LONDON (ShareCast) - (Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.
Hiscock, previously chief executive and CFO of everyLIFE Technologies, a technology business delivering digital care planning solutions to social care providers, will start in the role with immediate effect.

The AIM-listed group highlighted that Hiscock had held several CFO roles at both fast-growing listed and private companies over his 30-year career and was a member of the Institute of Chartered Accountants of Scotland.

As of 0940 BST, Bioventix shares were up 1.20% at 4,200p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,466.67p
Change Today 16.67p
% Change 0.68 %
52 Week High 4,050.00
52 Week Low 2,300.00
Volume 1,271
Shares Issued 5.22m
Market Cap £128.88m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 07-Oct-2025

Time Volume / Share Price
10:04 2 @ 2,440.00p
09:58 165 @ 2,400.00p
09:30 500 @ 2,442.00p
08:46 10 @ 2,450.00p
08:03 7 @ 2,450.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page